A Real-World Pharmacovigilance Analysis of the Safety Profiles Associated with Anti-MRSA Agents Using the Japanese Adverse Drug Event Report (JADER) Database

Yuki Hanai, Shusuke Uekusa, Mizuki Mori, Kohei Shimoyama, Hayato Ohashi, Koji Nishimura, Sachiko Yanagino, Takahiro Matsumoto, Kazuhiro Matsuo · 2026

Read A Real-World Pharmacovigilance Analysis of the Safety Profiles Associated with Anti-MRSA Agents Using the Japanese Adverse Drug Event Report (JADER) Database by Yuki Hanai, Shusuke Uekusa, Mizuki Mori, Kohei Shimoyama, Hayato Ohashi, Koji Nishimura, Sachiko Yanagino, Takahiro Matsumoto, Kazuhiro Matsuo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13214683.txt.

Description

Yuki Hanai and co-authors mine a national adverse drug event database in Japan to compare the safety profiles of six drugs used against MRSA, a hard-to-treat bacterium. The drugs are a last line for severe infections, and each has its own toxicity profile. Real-world comparisons have been scarce. Their 2026 pharmacovigilance study spans report years 2004 to 2025 and weighs which harms are reported disproportionately often for each drug.

Each drug showed its own pattern. One led on acute kidney failure and severe skin reactions, and another on eosinophilic pneumonia at a sky-high reporting rate. Another leaned toward blood disorders, low sodium, and metabolic acid build-up. Time-to-onset curves separated harms that accumulate with dose from harms that strike at random. The team urges monitoring tuned to each drug, and cross-checks in other data, before firm rules are set.

Catalog record

CREATORYuki Hanai, Shusuke Uekusa, Mizuki Mori, Kohei Shimoyama, Hayato Ohashi, Koji Nishimura, Sachiko Yanagino, Takahiro Matsumoto, Kazuhiro Matsuo
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13214683

Browse the full library · About the Tower of Babel